Capsaicin induction of esophageal symptoms in different phenotypes of gastroesophageal reflux disease

Revista de Gastroenterologia de Mexico

Volumn 75, Issue 4, 2010, Pages 396-404

  Herrera Lopez J A ^a   Mejia Rivas M A ^a   Vargas Vorackova, F ^a   Valdovinos Diaz M A ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Barrett's esophagus; Capsaicin; Erosive reflux disease; Gastroesophageal reflux disease; Mexico; Nonerosive reflux disease; Type 1 vanilloid receptors

Indexed keywords

AGENTS ACTING ON THE PERIPHERAL NERVOUS AND NEUROMUSCULAR SYSTEMS; CAPSAICIN; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROESOPHAGEAL REFLUX; GENETICS; HUMAN; MALE; MIDDLE AGED; PHENOTYPE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADULT; AGED; CAPSAICIN; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PROSPECTIVE STUDIES; SENSORY SYSTEM AGENTS; YOUNG ADULT;

EID: 84855439227     PISSN: 03750906     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. McQuaid KR, Laine L. Early heartburn relief with proton pump inhibitors: A systematic review and meta-analysis of clinical trials. Clin Gastroenterol Hepatol 2005;3:553-63. (Pubitemid 40824748)
2. Dent J, Armstrong D, Talley NJ et al. Symtom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut 2004;53(Suppl IV):IV1-IV24. (Pubitemid 38580755)
3. De Vault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005;100:190-200. (Pubitemid 41623288)
4. de Caestecker J. ABC of the upper gastrointestinal tract. Oesophagus: Heartburn. BMJ 2001;323:736-9. (Pubitemid 32929440)
5. Jones R, Galmiche JP. Review: What do we mean by GERD?-definition and diagnosis. Aliment Pharmacol Ther 2005;22(Suppl.1):2-10. (Pubitemid 41153074)
6. Traube M. The spectrum of the symptoms and presentations of gastroesophageal reflux disease. Gastroenterol Clin North Am 1990;19:609-616. (Pubitemid 20337444)
7. Quigley EMM: Factors that influence therapeutic outcomes in symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003; 98(Suppl):S24-S30. (Pubitemid 36348512)
8. Ronnie Fass. Distinct phenotypic presentations of gastroesophageal reflux disease: A new view of the natural history. Dig Dis 2004;22:100-107. (Pubitemid 39274304)
9. Shi G, Tatum R, Joehl R, Kahrilas P. Esophageal sensitivity and symptom perception in gastroesophageal reflux disease. Curr Gastroenterol Reports 1999;1:214-219.
10. Shay S. Esophageal impedance monitoring; The ups and downs of a new test. Am Gastroenterol 2004;99:1020-2. (Pubitemid 38917802)
11. Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring:review and concensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 2004;53:1024-1031. (Pubitemid 38824163)
12. I. Hirano. Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease-Bilitec, intraluminal impedance and Bravo capsule pH monitoring. Aliment Pharmacol Ther 2006;23(Suppl 1):12-24.
13. Pehlivanov N, Liu J, Mittal RK. Sustained esophageal contraction: a motor correlate of heartburn symptom. Am J Physiol Gastrointest Liver Physiol 2001;281:G743-G751.
14. Mittal R, Gui A, Liu J. The sustained esophageal contraction associated with heartburn of a positive Bernstein test is mediated through a non-cholinergic pathway. Gastroenterology 2001;120 (Suppl 1):A2149.
15. Rodriguez-Stanley S, Robinson M, Earnest D. et al. Esophageal hypersensitivity may be a major cause of heartburn. Am J Gastroenterol 1999; 94:628-631. (Pubitemid 29124857)
16. Bradley L, Richter J, Pulliam T. et al. The relationship between stress and symptom of gastroesophageal reflux: the influence of psychological factors. Am J Gastroenterol 1993;88:11-19 (Pubitemid 23017935)
17. Naliboff B, Mayer M, Fass R, et al. The effect of life stress on symptoms of heartburn. Psychosom Med 2004;66:426-34. (Pubitemid 38668416)
18. Salgado-Aros S, Camilleri M. Visceral hypersensitivity. J Clin Gastroenterol 2005;39:S194-S203. (Pubitemid 44638346)
19. Fass R. Sensory testing of the esophagus. J Clin Gastroenterol 2004;38: 628-641. (Pubitemid 39096790)
20. Pellegrini F, Taddei A, Bizzoco E, et al. Distribution of the vanilloid (capsaicin) receptor type 1 in thehuman stomach. Histochem Cell Biol 2005;124:61-8. (Pubitemid 41253163)
21. Dömötör A, Peidl Z, Vincze A, et al. Inmunohistochemical distribution of vanilloid receptor, calcitonin-gene related peptide and substance P in gastrointestinal mucosa of patients with different gastrointestinal disorders. Inflammopharmacology 2005;13:161-177. (Pubitemid 41607377)
22. Chan CL, Davis JB, Smith GD, et al. Sensory fibers expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and faecal urgency. Lancet 2005;361:385-391. (Pubitemid 36164972)
23. Yiangou Y, Facer P, Dyer NH, et al. Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet 2001;357:1338-1339. (Pubitemid 32441536)
24. Szallasi A, Blumberg PM. Vanilloid (capsaicin) receptor and mechanisms. Pharmacological Rev 1999;51:159-211.
25. Cortright DN, Szallasi A. Biochemical pharmacology of the vanilloid receptor TRPV1. Eur J Biochem 2004;271:1814-1819. (Pubitemid 38657335)
26. Matthews P, Aziz Q, Facer P, et al. Increased capsaicin r receptor TRPV1 nerve fibres in theinflamed human oesophagus. Eur J Gastroenterol Hepatol 2004;16:897-902. (Pubitemid 39179660)
27. Bhalia V, Liu J, Mittal RK. Nature of symptoms induce by vanilloid receptor activation in the human esophagus. Gastroenterology 2004; 126: A111. 28
28. Kindt S, Vos R, Tack J. influence of intra-esophageal capsaicin instillation on heartburn induction and desensitization in man. Gastroenterology 2006;130(Suppl 2):A392.
29. Holzer P. Capsaicin: Cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1991;143: 201.
30. Pingle SC, Matta JA, Ahern GP. Capsaicin receptor: TRPV1 a promiscuous TRP channel. Handb Exp Pharmacol 2007;179:155-171.
31. Klauser AG. Symtoms in gastro-oesophageal reflux disease. Lancet 1990;335:205
32. Jean Paul Galmiche and Stanislas Bruley des Varannes. Endoscopy-negative reflux disease. Curr Gastroenterol Reports 2001;3:206-214.
33. Chey WD. Endoscopy-negative reflux disease: Concepts and clinical practice. Am J Med 2004;117:36S-43S.
34. Lundell LR, Dent J, Bennett J, et al. Endoscopic assessment of oesophagitis: Clinical and functional correlations and further validation of the Los Angeles classification. Gut 1999;45:172-180. (Pubitemid 29333764)
35. Coron E, Hatlebakk JG, Galmiche JP. Novel developments in non-erosive and erosive gastroesophageal reflux disease. Curr Op Gastroenterol 2006;22:399-405. (Pubitemid 44090196)
36. Bonino JA, Sharma P. Barrett's esophagus. Curr Op Gastroenterol 2006;22:406-411. (Pubitemid 44090197)
37. Watson A, Heading RC, Shepherd NA. British Society of Gastroenterology. Guidelines for the diagnosis and management of Barrett's columnar-lined oesophagus [monograph on the Internet]. British Society of Gastroenterology; 2005 [cited 2010 September 27th]. Available from: http://www.bsg.org. uk/clinical-guidelines/oesophageal/guidelines-for-the-diagnosis-and-management- of-barrett-s-columnar-lined-oesophagus.html.
38. Carlsson R, Dent J, Bolling-Sternevald E, et al. The usefulness of a structured questinnaire in the assessment of symptomatic gastroesophageal reflux disease. Scand J Gastroenterol 1998;33:1023-9. (Pubitemid 28505643)
39. Gracely RH, McGrath F, Dubner R. Ratio scales of sensory and effective verbal pain descriptors. Pain 1978;5:5-18. (Pubitemid 8358130)
40. Lauria G, Morbin M, Lombarda R, et al. Expression of capsaicin receptor inmunoreactivity in human peripheral nervous system and in painful neuropathies. J Peripher Nerv Syst. 2006;11:262-71. (Pubitemid 44286078)
41. Cruz F. Desensitization of bladder sensory fibers by intravesical capsaicin or capsaicin analogs. A new strategy for treatment of urge incontinence in patients with spinal detrusor hyperreflexia of bladder hypersensitivity disorders. Int Urogynecol J Pelvic Floor Dysfunct 1998;9:214-20.
42. Bloom HM, Van RijswiijK JB, Garrelds IM. Et al. Intranasal capsaicin is effifi-cacious in non-infectious perenial rhinitis. A placebo-controlled study. Clin Exp Allergy 1997;27:796-801. (Pubitemid 27306159)
43. Ellis CN, Berberian B, Sulica VI, et al. A double-blind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad Dermatol 1993;29:438-442. (Pubitemid 23260133)
44. Bernstein JE, Bickers DR, Dahl M. et al. Treatment of chronic postherpetic neuralgia with topical capsaicin. J Am Acad Dermatol 1987;17: 93-96. (Pubitemid 17087202)
45. Capsaicin study group. Treatment of painful diabetic neuropathy with topical capsaicin. Arch Inter Med 1991;151:2225-2229.
46. Watson CPN and Evans RJ. The postmastectomy pain syndrome and topical capsaicin: A randomized trial. Pain 1992;51:375-379 (Pubitemid 23005876)
47. Gonzalez R, Dunkel R, Koletzko B. et al. Effect of capsaicin-containing red pepper sauce suspension on upper gastrointestinal motility in healthy volunteers. Dig Dis Sci 1998;43:1165-1171. (Pubitemid 28272546)
48. Grossi L, Capello G and Marzio L. Effect of an acute intraluminal administration oj capsaicin on oesophageal motor pattern in GORD patients with ineffective oesophageal motility. Neurogastroenterol Motil 2006;18:632-636. (Pubitemid 44079766)
49. Bortolotti M, Cocía G, Grossi G et al. The treatment of functional dispepsia with red pepper. Aliment Pharmacol Ther 2002;16:1075-1082. (Pubitemid 34680749)
50. Ingle SC, Matta JA, Ahern GP. Capsaicin receptor: TRPV1 a promiscuos TRP channel. Handb Exp Pharmacol. 2007;179:155-71.
51. Yasser M. Bhat and Klaus Bielefeldt. Capsaicin receptor (TRPV1) an non-erosive reflux disease. Eur J Gastroenterol Hepatol 2006;18:263-270.
52. Dickman R, Pasricha P, Winston J et al. Patients with non-erosive reflux disease (NERD) demonstrate upregulation of TRPV1 receptors in the distal esophagus as compared to the other GERD groups. Gastroenterology 2006;130(Suppl 2): A392.
53. Rodríguez-Stanley S, Collings KL, Robinson M, et al. The effects of capsaicin on reflux, gastric emptying and dyspepsia. Aliment Pharmacol Ther 2000;14:129-134. (Pubitemid 30058171)